Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of ...

Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, ...

Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.

The medical device supplier said that a threat actor accessed company systems through a social engineering attack.

Zimmer Biomet said Tuesday it has appointed Chintan Desai president of its Asia Pacific region, effective immediately. Desai ...

The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the ...

The program, a partnership with Kinomatic, will use biometric data and care coordination between visits to support recovery ...

We have all this data that’s available, but it’s actually not actionable because we don’t have a way to get it into clinical ...

The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after ...

The draft agreement outlines the Food and Drug Administration’s goals for medical device reviews from 2028 to 2032.

Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources ...